✦ LIBER ✦

Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy

✍ Scribed by Aya Matsumoto; Toshihiro Higuchi; Shigeo Yura; Masaki Mandai; Masatoshi Kariya; Kenji Takakura; Shingo Fujii

Book ID: 109006565
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 169 KB
Volume: 32
Category: Article
ISSN: 1341-8076
DOI: 10.1111/j.1447-0756.2006.00460.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of secondary cytoreductive surg

The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma

✍ Scott M. Eisenkop; Richard L. Friedman; Nick M. Spirtos 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views

BACKGROUND. This study examined the impact of secondary cytoreductive surgery on survival of patients with recurrent epithelial ovarian carcinoma. ## METHODS. One hundred six patients with a disease free interval (DFI) Ͼ 6 months after primary treatment underwent secondary cytoreductive surgery. M

Secondary cytoreductive surgery in the m

Secondary cytoreductive surgery in the management of platinum-sensitive recurrent epithelial ovarian cancer

✍ Jeong-Yeol Park; Jeong-Min Eom; Dae-Yeon Kim; Jong-Hyeok Kim; Yong-Man Kim; Youn 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Role of chemotherapy for patients with r

Role of chemotherapy for patients with recurrent platinum-resistant advanced epithelial ovarian cancer : A cost-effectiveness analysis

✍ Rodney P. Rocconi; Ashley S. Case; J. Michael Straughn Jr.; Jacob M. Estes; Edwa 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

Role of salvage chemotherapy with topote

Role of salvage chemotherapy with topotecan and cisplatin in patients with paclitaxel- and platinum-resistant recurrent ovarian or primary peritoneal cancer: A phase II pilot study

✍ Ghamande, Sharad A.; Piver, M. Steven 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

## Background and Objectives: We assessed the role of salvage chemotherapy with topotecan and cisplatin in patients with platinum-and paclitaxel-resistant advanced and recurrent ovarian or primary peritoneal cancer, based on the reported in vivo and in vitro synergism between these two drugs. Meth

Enhanced repair of DNA interstrand cross

Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy

✍ Wynne, P; Newton, C; Ledermann, J A; Olaitan, A; Mould, T A; Hartley, J A 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 147 KB

Surgery in recurrent epithelial ovarian

Surgery in recurrent epithelial ovarian cancer: Benefits on Survival for patients with residual disease of 0.1–1 cm after secondary cytoreduction

✍ Wen-Juan Tian; Rong Jiang; Xi Cheng; Jie Tang; Yan Xing; Rong-Yu Zang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

## Abstract ## Aims Recent retrospective trials stated that a benefit of surgery for recurrent ovarian cancer may be limited to patients in whom a complete cytoreduction (R0) could be achieved. Most of them pointed out there was no difference in survival between residual disease of 0.1–1 cm (R1) a